{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T17:37:25Z","timestamp":1794937045395,"version":"4.9.1"},"reference-count":46,"publisher":"BMJ","issue":"7","license":[{"start":{"date-parts":[[2020,4,9]],"date-time":"2020-04-09T00:00:00Z","timestamp":1586390400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000266","name":"Engineering and Physical Sciences Research Council","doi-asserted-by":"publisher","award":["EP\/M006204\/1"],"award-info":[{"award-number":["EP\/M006204\/1"]}],"id":[{"id":"10.13039\/501100000266","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013999","name":"Garfield Weston Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013999","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["097479\/Z\/11\/Z"],"award-info":[{"award-number":["097479\/Z\/11\/Z"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["J Neurol Neurosurg Psychiatry"],"accepted":{"date-parts":[[2020,3,23]]},"published-print":{"date-parts":[[2020,7]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Parkinson\u2019s disease is characterised neuropathologically by \u03b1-synuclein aggregation. Currently, there is no blood test to predict the underlying pathology or distinguish Parkinson\u2019s from atypical parkinsonian syndromes. We assessed the clinical utility of serum neuronal exosomes as biomarkers across the spectrum of Parkinson\u2019s disease, multiple system atrophy and other proteinopathies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We performed a cross-sectional study of 664 serum samples from the Oxford, Kiel and Brescia cohorts consisting of individuals with rapid eye movement sleep behavioural disorder, Parkinson\u2019s disease, dementia with Lewy bodies, multiple system atrophy, frontotemporal dementia, progressive supranuclear palsy, corticobasal syndrome and controls. Longitudinal samples were analysed from Parkinson\u2019s and control individuals. We developed poly(carboxybetaine-methacrylate) coated beads to isolate L1 cell adhesion molecule (L1CAM)-positive extracellular vesicles with characteristics of exosomes and used mass spectrometry or multiplexed electrochemiluminescence to measure exosomal proteins.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Mean neuron-derived exosomal \u03b1-synuclein was increased by twofold in prodromal and clinical Parkinson\u2019s disease when compared with multiple system atrophy, controls or other neurodegenerative diseases. With 314 subjects in the training group and 105 in the validation group, exosomal \u03b1-synuclein exhibited a consistent performance (AUC=0.86) in separating clinical Parkinson\u2019s disease from controls across populations. Exosomal clusterin was elevated in subjects with non-\u03b1-synuclein proteinopathies. Combined neuron-derived exosomal \u03b1-synuclein and clusterin measurement predicted Parkinson\u2019s disease from other proteinopathies with AUC=0.98 and from multiple system atrophy with AUC=0.94. Longitudinal sample analysis showed that exosomal \u03b1-synuclein remains stably elevated with Parkinson\u2019s disease progression.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Increased \u03b1-synuclein egress in serum neuronal exosomes precedes the diagnosis of Parkinson\u2019s disease, persists with disease progression and in combination with clusterin predicts and differentiates Parkinson\u2019s disease from atypical parkinsonism.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/jnnp-2019-322588","type":"journal-article","created":{"date-parts":[[2020,4,9]],"date-time":"2020-04-09T17:05:44Z","timestamp":1586451944000},"page":"720-729","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":269,"title":["Serum neuronal exosomes predict and differentiate Parkinson\u2019s disease from atypical parkinsonism"],"prefix":"10.1136","volume":"91","author":[{"given":"Cheng","family":"Jiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franziska","family":"Hopfner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antigoni","family":"Katsikoudi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Hein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Candan","family":"Catli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Evetts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2503-1589","authenticated-orcid":false,"given":"Yongzhi","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John W","family":"Ryder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregor","family":"Kuhlenbaeumer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guenther","family":"Deuschl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Padovani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Berg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9340-9814","authenticated-orcid":false,"given":"Barbara","family":"Borroni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele T","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason J","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9252-5933","authenticated-orcid":false,"given":"George K","family":"Tofaris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2020,4,9]]},"reference":[{"key":"2024111108300555000_91.7.720.1","doi-asserted-by":"publisher","DOI":"10.1016\/S0197-4580(02)00065-9"},{"key":"2024111108300555000_91.7.720.2","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-007-7217-5"},{"key":"2024111108300555000_91.7.720.3","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(11)70014-X"},{"key":"2024111108300555000_91.7.720.4","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1002\/mds.27110","article-title":"Diagnostic utility of cerebrospinal fluid \u03b1-synuclein in Parkinson's disease: a systematic review and meta-analysis","volume":"32","author":"Eusebi","year":"2017","journal-title":"Mov Disord"},{"key":"2024111108300555000_91.7.720.5","doi-asserted-by":"publisher","DOI":"10.1096\/fj.02-0408rev"},{"key":"2024111108300555000_91.7.720.6","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2010.06.009"},{"key":"2024111108300555000_91.7.720.7","doi-asserted-by":"crossref","first-page":"569","DOI":"10.3233\/JPD-171176","article-title":"A critical assessment of exosomes in the pathogenesis and stratification of Parkinson's disease","volume":"7","author":"Tofaris","year":"2017","journal-title":"J Parkinsons Dis"},{"key":"2024111108300555000_91.7.720.8","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1002\/acn3.175","article-title":"Identification of distinct circulating exosomes in Parkinson's disease","volume":"2","author":"Tomlinson","year":"2015","journal-title":"Ann Clin Transl Neurol"},{"key":"2024111108300555000_91.7.720.9","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-014-1314-y"},{"key":"2024111108300555000_91.7.720.10","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2018.00125","article-title":"The Exosomal\/Total \u03b1-synuclein ratio in plasma is associated with glucocerebrosidase activity and correlates with measures of disease severity in PD patients","volume":"12","author":"Cerri","year":"2018","journal-title":"Front Cell Neurosci"},{"key":"2024111108300555000_91.7.720.11","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2013.09.025"},{"key":"2024111108300555000_91.7.720.12","doi-asserted-by":"crossref","DOI":"10.1186\/s40035-019-0153-0","article-title":"No association between Parkinson disease and autoantibodies against NMDA-type glutamate receptors","volume":"8","author":"Hopfner","year":"2019","journal-title":"Transl Neurodegener"},{"key":"2024111108300555000_91.7.720.13","doi-asserted-by":"crossref","first-page":"3108","DOI":"10.1016\/j.neurobiolaging.2015.07.019","article-title":"Early stage of behavioral variant frontotemporal dementia: clinical and neuroimaging correlates","volume":"36","author":"Borroni","year":"2015","journal-title":"Neurobiol Aging"},{"key":"2024111108300555000_91.7.720.14","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.55.3.181"},{"key":"2024111108300555000_91.7.720.15","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.47.1.1"},{"key":"2024111108300555000_91.7.720.16","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e31827f0fd1"},{"key":"2024111108300555000_91.7.720.17","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000324625.00404.15"},{"key":"2024111108300555000_91.7.720.18","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1212\/WNL.0000000000004058","article-title":"Diagnosis and management of dementia with Lewy bodies","volume":"89","author":"McKeith","year":"2017","journal-title":"Neurology"},{"key":"2024111108300555000_91.7.720.19","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e31821103e6"},{"key":"2024111108300555000_91.7.720.20","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awr179"},{"key":"2024111108300555000_91.7.720.21","doi-asserted-by":"crossref","first-page":"1535750","DOI":"10.1080\/20013078.2018.1535750","article-title":"Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for extracellular vesicles and update of the MISEV2014 guidelines","volume":"7","author":"Th\u00e9ry","year":"2018","journal-title":"J Extracell Vesicles"},{"key":"2024111108300555000_91.7.720.22","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e3181fc29c9"},{"key":"2024111108300555000_91.7.720.23","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awp244"},{"key":"2024111108300555000_91.7.720.24","doi-asserted-by":"publisher","DOI":"10.1002\/ana.22655"},{"key":"2024111108300555000_91.7.720.25","doi-asserted-by":"publisher","DOI":"10.1038\/ncb748"},{"key":"2024111108300555000_91.7.720.26","doi-asserted-by":"publisher","DOI":"10.1038\/ng.440"},{"key":"2024111108300555000_91.7.720.27","doi-asserted-by":"publisher","DOI":"10.1038\/ng.439"},{"key":"2024111108300555000_91.7.720.28","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/s40478-017-0481-1","article-title":"Clusterin protects neurons against intracellular proteotoxicity","volume":"5","author":"Gregory","year":"2017","journal-title":"Acta Neuropathol Commun"},{"key":"2024111108300555000_91.7.720.29","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3002566"},{"key":"2024111108300555000_91.7.720.30","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1021\/acssensors.6b00532","article-title":"Unique sensing interface that allows the development of an electrochemical immunosensor for the detection of tumor necrosis factor \u03b1 in whole blood","volume":"1","author":"Jiang","year":"2016","journal-title":"ACS Sens."},{"key":"2024111108300555000_91.7.720.31","doi-asserted-by":"publisher","DOI":"10.1016\/j.jalz.2014.06.008"},{"key":"2024111108300555000_91.7.720.32","doi-asserted-by":"publisher","DOI":"10.1096\/fj.14-262048"},{"key":"2024111108300555000_91.7.720.33","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurobiolaging.2008.03.015"},{"key":"2024111108300555000_91.7.720.34","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.74.7.852"},{"key":"2024111108300555000_91.7.720.35","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-008-0346-6"},{"key":"2024111108300555000_91.7.720.36","doi-asserted-by":"publisher","DOI":"10.1002\/mds.25136"},{"key":"2024111108300555000_91.7.720.37","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1109356108"},{"key":"2024111108300555000_91.7.720.38","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0029460"},{"key":"2024111108300555000_91.7.720.39","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1523597113"},{"key":"2024111108300555000_91.7.720.40","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2011.01.029"},{"key":"2024111108300555000_91.7.720.41","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-018-0816-2"},{"key":"2024111108300555000_91.7.720.42","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s11011-018-0325-0","article-title":"Association between clusterin concentration and dementia: a systematic review and meta-analysis","volume":"34","author":"Yang","year":"2019","journal-title":"Metab Brain Dis"},{"key":"2024111108300555000_91.7.720.43","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.neurobiolaging.2019.02.017","article-title":"ApoE and clusterin CSF levels influence associations between APOE genotype and changes in CSF tau, but not CSF A\u03b242, levels in non-demented elderly","volume":"79","author":"Slot","year":"2019","journal-title":"Neurobiol Aging"},{"key":"2024111108300555000_91.7.720.44","unstructured":"Shepherd CE , Affleck AJ , Bahar AY , et al . Intracellular and secreted forms of clusterin are elevated early in Alzheimer's disease and associate with both A\u03b2 and tau pathology. Neurobiol Aging 2019:pii: S0197-4580(19)30389-6."},{"key":"2024111108300555000_91.7.720.45","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awy146"},{"key":"2024111108300555000_91.7.720.46","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000001364"}],"container-title":["Journal of Neurology, Neurosurgery &amp; Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jnnp-2019-322588","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,11]],"date-time":"2024-11-11T11:31:14Z","timestamp":1731324674000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnnp.bmj.com\/lookup\/doi\/10.1136\/jnnp-2019-322588"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,9]]},"references-count":46,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2020,6,18]]},"published-print":{"date-parts":[[2020,7]]}},"alternative-id":["10.1136\/jnnp-2019-322588"],"URL":"https:\/\/doi.org\/10.1136\/jnnp-2019-322588","relation":{},"ISSN":["0022-3050","1468-330X"],"issn-type":[{"value":"0022-3050","type":"print"},{"value":"1468-330X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,9]]}}}